Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$1.04 - $1.89 $45,179 - $82,105
-43,442 Reduced 79.8%
10,999 $12,000
Q1 2023

May 15, 2023

SELL
$1.65 - $2.03 $121,382 - $149,336
-73,565 Reduced 57.47%
54,441 $95,000
Q4 2022

Feb 14, 2023

SELL
$1.64 - $2.48 $98,550 - $149,028
-60,092 Reduced 31.95%
128,006 $209,000
Q3 2022

Nov 14, 2022

BUY
$1.92 - $5.04 $13,464 - $35,345
7,013 Added 3.87%
188,098 $372,000
Q2 2022

Aug 15, 2022

SELL
$3.39 - $4.69 $29,550 - $40,882
-8,717 Reduced 4.59%
181,085 $694,000
Q1 2022

May 16, 2022

BUY
$4.3 - $7.26 $153,316 - $258,855
35,655 Added 23.13%
189,802 $901,000
Q4 2021

Feb 14, 2022

SELL
$6.74 - $10.69 $347,265 - $550,780
-51,523 Reduced 25.05%
154,147 $1.07 Million
Q3 2021

Nov 15, 2021

SELL
$10.3 - $13.45 $229,164 - $299,249
-22,249 Reduced 9.76%
205,670 $2.27 Million
Q2 2021

Aug 16, 2021

BUY
$8.84 - $12.46 $861,095 - $1.21 Million
97,409 Added 74.64%
227,919 $2.64 Million
Q1 2021

May 17, 2021

BUY
$11.15 - $21.5 $1.22 Million - $2.34 Million
109,044 Added 507.98%
130,510 $1.67 Million
Q4 2020

Feb 16, 2021

BUY
$6.7 - $15.02 $143,822 - $322,419
21,466 New
21,466 $231,000

Others Institutions Holding RVP

About RETRACTABLE TECHNOLOGIES INC


  • Ticker RVP
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 32,937,200
  • Market Cap $19.4M
  • Description
  • Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. It offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adap...
More about RVP
Track This Portfolio

Track D. E. Shaw & Co., Inc. Portfolio

Follow D. E. Shaw & Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.